Fiche centre
Juntendo University Hospital
Tokyo — Japan
Essais liés5clinical trials
VilleTokyolocalisation
PaysJapanlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06531824
Essais cliniques associés
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Tamibarotene | Insuffisance cardiaque | Phase 2 | NCT07855692 | The Clinical Trial of Tamibarotene for Patients With HFpEF (RELIEF Trial) | RECRUITING |
| HS-001 CS | Insuffisance cardiaque | Phase 1/2 | NCT04945018 | A Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Heart Failure (LAPiS Study) | COMPLETED |
| MB-CART2019.1 | SEP | Phase 2 | NCT07288879 | DALY II Japan/MB-CART2019.1 for DLBCL | RECRUITING |
| BI 690517 | Maladie rénale chronique | Phase 3 | NCT06531824 | EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) | ACTIVE_NOT_RECRUITING |
| Pegcetacoplan (APL-2) | Sclérose latérale amyotrophique | Phase 2 | NCT04579666 | MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS) | TERMINATED |